Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

HR

Healthcare Realty Trust Inc Reduces Board Size

Healthcare Realty Trust Incorporated (NYSE:HR) has announced a reduction in the size of its board of directors from 12 to 7 members. This change is part of an effort to better align the board size with industry standards and best practices of corporate governance.

As a result of this reduction, five directors voluntarily retired from the board, effective June 18, 2025. The retiring directors are Nancy Agee, Ajay Gupta, James Kilroy, Peter Lyle, and Christann Vasquez. The board expressed gratitude for their service and contributions to the company, acknowledging the valuable perspectives and insights they provided over the years.

The remaining board now consists of seven directors, including the independent chairman Thomas Bohjalian, CEO Peter Scott, and independent directors David Henry, Jay Leupp, Constance Moore, Glenn Rufrano, and Donald Wood.

Healthcare Realty President and CEO Peter Scott expressed his anticipation to work with the continuing directors and enhance relationships with stakeholders. He emphasized the company's high-quality portfolio and strong industry fundamentals, expressing excitement about the future.

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The company's portfolio includes over 640 properties totaling over 38 million square feet concentrated in 15 growth markets.

As a result of these announcements, the company's shares have moved 1.65% on the market, and are now trading at a price of $15.43. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS